Please use this identifier to cite or link to this item:
Telemedicine for diabetes care in India during COVID19 pandemic and national lockdown period: Guidelines for physicians.
A Ghosh.
R Gupta.
A Misra.
Acceso Abierto
BACKGROUND AND AIMS:In view of restrictions on mobility of patients because of COVID-19 pandemic, face-to-face consultations are difficult. We sought to study the feasibility of telemedicine in this scenario. METHODS:PubMed and Google Scholar search engines were searched using the key terms 'telemedicine', 'diabetes', 'COVID-19 up to 31st March 2020. In addition, existing guidelines including those by Ministry of Health and Family Welfare (MOHFW), Government of India, were accessed. RESULTS:We discuss evidence and general guidelines regarding role of telemedicine in patients with diabetes along with its utility and limitations. CONCLUSIONS:Telemedicine is a useful tool for managing patients of diabetes during this lockdown period. However, there is limited data and further research is required.
Diabetes & metabolic syndrome
Appears in Collections:Artículos científicos

Upload archives

File SizeFormat 
1105045.pdf487.42 kBAdobe PDFView/Open